BioMaxima S.A. (WSE:BMX)

Poland flag Poland · Delayed Price · Currency is PLN
12.05
-0.10 (-0.82%)
Mar 3, 2026, 5:00 PM CET
-13.62%
Market Cap 50.95M
Revenue (ttm) 59.11M
Net Income (ttm) 649.00K
Shares Out 4.19M
EPS (ttm) 0.15
PE Ratio 81.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,863
Average Volume 3,553
Open 12.15
Previous Close 12.15
Day's Range 11.95 - 12.15
52-Week Range 10.70 - 15.65
Beta 0.23
RSI 36.81
Earnings Date Apr 30, 2026

About BioMaxima

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which includes real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibiotics, agaroses and molecular biology media, media and buffers for in v... [Read more]

Sector Healthcare
Founded 1997
Employees 135
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BMX
Full Company Profile

Financial Performance

In 2024, BioMaxima's revenue was 52.85 million, an increase of 12.96% compared to the previous year's 46.79 million. Earnings were 535,000, a decrease of -8.70%.

Financial Statements

News

There is no news available yet.